Wipes Plus

Isoprpoyl Alcohol


Progressive Products, Llc
Human Otc Drug
NDC 67151-505
Wipes Plus also known as Isoprpoyl Alcohol is a human otc drug labeled by 'Progressive Products, Llc'. National Drug Code (NDC) number for Wipes Plus is 67151-505. This drug is available in dosage form of Swab. The names of the active, medicinal ingredients in Wipes Plus drug includes Isopropyl Alcohol - 70 mL/100mL . The currest status of Wipes Plus drug is Active.

Drug Information:

Drug NDC: 67151-505
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Wipes Plus
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Isoprpoyl Alcohol
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Progressive Products, Llc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Swab
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ISOPROPYL ALCOHOL - 70 mL/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 04 Sep, 2020
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 11 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part333E
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Progressive Products, LLC
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:797544
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:ND2M416302
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
67151-505-021 PACKAGE in 1 PACKAGE (67151-505-02) / 1 mL in 1 PACKAGE04 Sep, 2020N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose antiseptic

Product Elements:

Wipes plus isoprpoyl alcohol water isopropyl alcohol isopropyl alcohol

Indications and Usage:

Uses for hand sanitizing to decrease bacteria on the skin.

Warnings:

Warnings for external use only may irritate eyes keep our of reach of children keep our of reach of children unless under adult supervision

Dosage and Administration:

Directions tear open package. pull out wipe. apply topically to the skin

Package Label Principal Display Panel:

Principal display panel ndc 67151-505-02 wipes plus ® hand sanitizing wipe 1 wipe/trapo/linges not for retail sale reorder no/item no 35014 label

Further Questions:

Questions or comments emergency telephone # infotrac 1-800-535-5053 (north am.) 1-352-323-3500 (int.)


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.